Zhu Y, Si M, Wang L, Zhang Y, et al. Tolerability, safety, and preliminary immunogenicity assessment of different dosages of Quadrivalent inactivated influenza vaccine in healthy subjects aged 6-35 months: A single-center, dose-escalation, open-label phase I clinical trial. Vaccine 2025;68:127962.
PMID: 41207071